These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2380086)

  • 81. [A simple dose-effect model for the optimization of IMRT].
    Sauer OA
    Z Med Phys; 2001; 11(4):261-7. PubMed ID: 11820183
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Use of a linear-quadratic model for evaluation of late post-radiation complications in the larynx].
    Maciejewski B; Withers HR; Taylor JM
    Nowotwory; 1987; 37(1):67-76. PubMed ID: 3628033
    [No Abstract]   [Full Text] [Related]  

  • 83. A unified approach to dose-effect relationships in radiotherapy. II: Inhomogeneous dose distributions.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1988 Mar; 14(3):557-60. PubMed ID: 3343164
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Radiotoxic model for three-dimensional treatment planning. Part 1: Theoretical basis.
    Caudry M; Causse N; Trouette R; Récaldini L; Maire JP; Demeaux H
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):907-19. PubMed ID: 8478243
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Predicting normal tissue injury in radiation therapy.
    Wollin M; Kagan AR; Norman A
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1373-6. PubMed ID: 1938538
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A new theoretical formula for fractionated radiotherapy based on a saturable cellular repair mechanism.
    Sánchez-Reyes A; Farrús B; Biete A
    Acta Oncol; 1993; 32(1):57-62. PubMed ID: 8466765
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Linear quadratic model and biologically equivalent dose for single fraction treatments.
    Prasad SC
    Med Dosim; 1992; 17(2):101-2. PubMed ID: 1616587
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.
    Dale RG
    Radiother Oncol; 1989 Aug; 15(4):371-81. PubMed ID: 2798939
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment volume and tissue tolerance.
    Withers HR; Taylor JM; Maciejewski B
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):751-9. PubMed ID: 3350731
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Linear-quadratic model isoeffect relations for proliferating tumor cells for treatment with multiple fractions per day.
    Yaes RJ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):901-5. PubMed ID: 2777681
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The response of tumours with Gompertzian growth characteristics to fractionated radiotherapy.
    O'Donoghue JA
    Int J Radiat Biol; 1997 Sep; 72(3):325-39. PubMed ID: 9298113
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Research of Biological Dose Conversion Platform Based on a Modified Linear Quadratic Model.
    Dai LY; Huang RH; Zhou Y; le Gu H; Wang YB; Yang CCJ; Xu X; Ye M; Bai YR; Liu YL; Li XB; Ma XM
    Dose Response; 2019; 17(1):1559325819828623. PubMed ID: 30944552
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A mathematical model of the volume effect which postulates cell migration from unirradiated tissues.
    Shirato H; Mizuta M; Miyasaka K
    Radiother Oncol; 1995 Jun; 35(3):227-31. PubMed ID: 7480826
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fractionated radiation therapy after Strandqvist.
    Fowler JF
    Acta Radiol Oncol; 1984; 23(4):209-16. PubMed ID: 6093436
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Re: Danger in the use of hypofractionation.
    Stevens GN
    Australas Radiol; 1988 Aug; 32(3):410. PubMed ID: 3202760
    [No Abstract]   [Full Text] [Related]  

  • 96. Tumour and normal tissue responses to fractionated non-uniform dose delivery.
    Källman P; Agren A; Brahme A
    Int J Radiat Biol; 1992 Aug; 62(2):249-62. PubMed ID: 1355519
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hemoglobin, radiation, morbidity and survival.
    Dische S; Saunders MI; Warburton MF
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1335-7. PubMed ID: 3759555
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Postirradiation myelopathy in children.
    Kun LE
    Ann Neurol; 1979 Jan; 5(1):106. PubMed ID: 426464
    [No Abstract]   [Full Text] [Related]  

  • 99. Comparison of the predictions of the LQ and CRE models for normal tissue damage due to biologically targeted radiotherapy with exponentially decaying dose rates.
    O'Donoghue JA
    Radiother Oncol; 1989 Aug; 15(4):359-62. PubMed ID: 2798938
    [No Abstract]   [Full Text] [Related]  

  • 100. The pathogenesis of the late side-effects of radiotherapy.
    Michalowski A
    Clin Radiol; 1986 May; 37(3):203-7. PubMed ID: 3709043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.